Comprehensive Risk Stratification of Japanese Patients With Aortic Stenosis – A Proposal of a New Risk Score From the CHART-2 Study

Background:The risk of patients with aortic stenosis (AS) should be stratified not only by AS severity but also by comorbidities.Methods and Results:We aimed to develop a risk score for mortality in 412 patients with AS (pressure gradient ≥30 mmHg, mean age 74.9 years, male 52.4%) in the CHART-2 Stu...

Full description

Saved in:
Bibliographic Details
Published in:Circulation Journal Vol. 79; no. 7; pp. 1631 - 1638
Main Authors: Sato, Kenjiro, Sakata, Yasuhiko, Miura, Masanobu, Tadaki, Soichiro, Ushigome, Ryoichi, Yamauchi, Takeshi, Onose, Takeo, Tsuji, Kanako, Abe, Ruri, Nochioka, Kotaro, Takahashi, Jun, Miyata, Satoshi, Shimokawa, Hiroaki, on behalf of the CHART-2 Investigators
Format: Journal Article
Language:English
Published: Japan The Japanese Circulation Society 2015
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background:The risk of patients with aortic stenosis (AS) should be stratified not only by AS severity but also by comorbidities.Methods and Results:We aimed to develop a risk score for mortality in 412 patients with AS (pressure gradient ≥30 mmHg, mean age 74.9 years, male 52.4%) in the CHART-2 Study (n=10,219). During a 3-year follow-up, 73 (17.7%) patients died. Crude 3-year mortality of patients in New York Heart Association (NYHA) classes I, II, and III/IV was 9.5%, 16.5%, and 49.7%, respectively (P<0.001). Stepwise Cox regression analysis showed that the combination of 7 factors was the best model to predict the mortality of AS patients, who were scored according to their hazard ratios, including NYHA class III–IV (score 6), male sex (3), serum albumin level ≤4 g/dl (2), aortic peak flow ≥4.5 m/s (2), age ≥75 years (2), chronic kidney disease (2), and anemia (1). Receiver-operating characteristic analysis showed excellent association between the sum of the scores and 3-year mortality (area under the curve, 0.78). The multivariate Cox proportional hazard model demonstrated that the present risk score also well stratified the mortality risk.Conclusions:The present study demonstrates that, in addition to the classical prognostic factors related to symptoms and AS severity, various comorbidities are associated with mortality. Thus, the present comprehensive risk score may be useful for risk stratification of AS patients. (Circ J 2015; 79: 1631–1638)
AbstractList The risk of patients with aortic stenosis (AS) should be stratified not only by AS severity but also by comorbidities. We aimed to develop a risk score for mortality in 412 patients with AS (pressure gradient ≥30 mmHg, mean age 74.9 years, male 52.4%) in the CHART-2 Study (n=10,219). During a 3-year follow-up, 73 (17.7%) patients died. Crude 3-year mortality of patients in New York Heart Association (NYHA) classes I, II, and III/IV was 9.5%, 16.5%, and 49.7%, respectively (P<0.001). Stepwise Cox regression analysis showed that the combination of 7 factors was the best model to predict the mortality of AS patients, who were scored according to their hazard ratios, including NYHA class III-IV (score 6), male sex (3), serum albumin level ≤4 g/dl (2), aortic peak flow ≥4.5 m/s (2), age ≥75 years (2), chronic kidney disease (2), and anemia (1). Receiver-operating characteristic analysis showed excellent association between the sum of the scores and 3-year mortality (area under the curve, 0.78). The multivariate Cox proportional hazard model demonstrated that the present risk score also well stratified the mortality risk. The present study demonstrates that, in addition to the classical prognostic factors related to symptoms and AS severity, various comorbidities are associated with mortality. Thus, the present comprehensive risk score may be useful for risk stratification of AS patients.
Background:The risk of patients with aortic stenosis (AS) should be stratified not only by AS severity but also by comorbidities.Methods and Results:We aimed to develop a risk score for mortality in 412 patients with AS (pressure gradient ≥30 mmHg, mean age 74.9 years, male 52.4%) in the CHART-2 Study (n=10,219). During a 3-year follow-up, 73 (17.7%) patients died. Crude 3-year mortality of patients in New York Heart Association (NYHA) classes I, II, and III/IV was 9.5%, 16.5%, and 49.7%, respectively (P<0.001). Stepwise Cox regression analysis showed that the combination of 7 factors was the best model to predict the mortality of AS patients, who were scored according to their hazard ratios, including NYHA class III–IV (score 6), male sex (3), serum albumin level ≤4 g/dl (2), aortic peak flow ≥4.5 m/s (2), age ≥75 years (2), chronic kidney disease (2), and anemia (1). Receiver-operating characteristic analysis showed excellent association between the sum of the scores and 3-year mortality (area under the curve, 0.78). The multivariate Cox proportional hazard model demonstrated that the present risk score also well stratified the mortality risk.Conclusions:The present study demonstrates that, in addition to the classical prognostic factors related to symptoms and AS severity, various comorbidities are associated with mortality. Thus, the present comprehensive risk score may be useful for risk stratification of AS patients. (Circ J 2015; 79: 1631–1638)
BACKGROUNDThe risk of patients with aortic stenosis (AS) should be stratified not only by AS severity but also by comorbidities.METHODS AND RESULTSWe aimed to develop a risk score for mortality in 412 patients with AS (pressure gradient ≥30 mmHg, mean age 74.9 years, male 52.4%) in the CHART-2 Study (n=10,219). During a 3-year follow-up, 73 (17.7%) patients died. Crude 3-year mortality of patients in New York Heart Association (NYHA) classes I, II, and III/IV was 9.5%, 16.5%, and 49.7%, respectively (P<0.001). Stepwise Cox regression analysis showed that the combination of 7 factors was the best model to predict the mortality of AS patients, who were scored according to their hazard ratios, including NYHA class III-IV (score 6), male sex (3), serum albumin level ≤4 g/dl (2), aortic peak flow ≥4.5 m/s (2), age ≥75 years (2), chronic kidney disease (2), and anemia (1). Receiver-operating characteristic analysis showed excellent association between the sum of the scores and 3-year mortality (area under the curve, 0.78). The multivariate Cox proportional hazard model demonstrated that the present risk score also well stratified the mortality risk.CONCLUSIONSThe present study demonstrates that, in addition to the classical prognostic factors related to symptoms and AS severity, various comorbidities are associated with mortality. Thus, the present comprehensive risk score may be useful for risk stratification of AS patients.
Author Nochioka, Kotaro
Sato, Kenjiro
Sakata, Yasuhiko
Onose, Takeo
Miyata, Satoshi
Abe, Ruri
Shimokawa, Hiroaki
Takahashi, Jun
Tadaki, Soichiro
Miura, Masanobu
Tsuji, Kanako
on behalf of the CHART-2 Investigators
Yamauchi, Takeshi
Ushigome, Ryoichi
Author_xml – sequence: 1
  fullname: Sato, Kenjiro
  organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
– sequence: 2
  fullname: Sakata, Yasuhiko
  organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
– sequence: 3
  fullname: Miura, Masanobu
  organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
– sequence: 4
  fullname: Tadaki, Soichiro
  organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
– sequence: 5
  fullname: Ushigome, Ryoichi
  organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
– sequence: 6
  fullname: Yamauchi, Takeshi
  organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
– sequence: 7
  fullname: Onose, Takeo
  organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
– sequence: 8
  fullname: Tsuji, Kanako
  organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
– sequence: 9
  fullname: Abe, Ruri
  organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
– sequence: 10
  fullname: Nochioka, Kotaro
  organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
– sequence: 11
  fullname: Takahashi, Jun
  organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
– sequence: 12
  fullname: Miyata, Satoshi
  organization: Department of Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine
– sequence: 13
  fullname: Shimokawa, Hiroaki
  organization: Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
– sequence: 14
  fullname: on behalf of the CHART-2 Investigators
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25947000$$D View this record in MEDLINE/PubMed
BookMark eNpFkMtO3DAUhq2KqlzafVfIy25CfcvFy1HUgY4QIErVpWWcE8bTJE5tDxW72fEAvGH7InWYKcjSsWV9_y-d7xDtDW4AhD5SckJZzj8b683qpF5kNM8IKdgbdEC5KDNRMbL3_C4yWQm-jw5DWBHCJMnlO7TPcilKQsgBeqxdP3pYwhDsPeBrG37ib9HraFtr0nQDdi1e6FEPEABfpS8YYsA_bFzimfPRmsTD4IINfzebP5snPMNX3o0u6G6KanwBv3e9xnnAc-96HJeA67PZ9U3GUnzdPLxHb1vdBfiwu4_Q9_mXm_osO788_VrPzjMjpIhZQU3TgmmB8duGG2qIZMBYyRoqqjydFrQkRcV1qStRFFRzbdqG5jwxnHF-hD5te0fvfq0hRNXbYKDr0n5uHRQtJGNSMMESSrao8S4ED60ave21f1CUqEm_etav6oWiuZr0p8jxrn1920PzEvjvOwHzLbAKUd_BC6AnkR3sGkupymm8Nr8CS-0VDPwfybGeWA
CitedBy_id crossref_primary_10_1016_j_jjcc_2016_10_018
crossref_primary_10_1093_eurjpc_zwae086
crossref_primary_10_1253_circj_CJ_16_0636
crossref_primary_10_1253_circj_CJ_15_0578
crossref_primary_10_1002_ejhf_405
Cites_doi 10.1016/j.jacc.2012.08.988
10.1161/CIR.0b013e31829e8776
10.1016/j.jacc.2009.04.079
10.1161/01.CIR.101.7.765
10.1253/circj.CJ-11-0135
10.1161/CIRCULATIONAHA.108.808857
10.1016/S0140-6736(06)69208-8
10.1016/j.amjcard.2004.05.055
10.1161/CIRCULATIONAHA.105.584102
10.1253/circj.CJ-12-0025
10.1016/j.jcmg.2009.11.019
10.1161/01.CIR.38.1S5.V-61
10.1016/0735-1097(90)90234-G
10.1161/CIRCULATIONAHA.109.909903
10.1016/j.jacc.2006.05.021
10.1253/circj.72.1265
10.1067/mhj.2001.117131
10.1016/j.jtcvs.2007.08.058
10.1253/circj.CJ-13-0127
10.1161/CIRCHEARTFAILURE.111.965020
10.1136/hrt.82.2.143
10.1093/eurheartj/ehs337
10.1016/0002-8703(80)90375-0
10.1056/NEJM200008313430903
10.1253/circj.CJ-11-0012
10.1253/circj.CJ-13-1009
10.1016/j.athoracsur.2006.07.048
10.1016/j.amjcard.2012.10.015
10.1161/CIRCULATIONAHA.104.495903
10.1253/circj.CJ-14-0162
ContentType Journal Article
Contributor Yahagi, Hirokazu
Tamada, Yoshiaki
Koyama, Jiro
Takeuchi, Masaharu
Sato, Kimio
Akai, Kenjiro
Fukui, Shigefumi
Katoh, Atsushi
Oyama, Shigeto
Endo, Hideaki
Suzuki, Shu
Fushimi, Etsuko
Takahashi, Nozomu
Shinozaki, Tsuyoshi
Fukahori, Kouhei
Takahashi, Kikuyo
Ogata, Masahiko
Sugai, Yoshinao
Kikuchi, Yoku
Nakagawa, Makoto
Yagi, Takuya
Nozaki, Eiji
Nozaki, Tetsuji
Matsui, Motoyuki
Nakayama, Masaharu
Goto, Toshikazu
Kanno, Hiroyuki
Fukuda, Koji
Nakano, Makoto
Komatsu, Seiji
Ishizuka, Takeshi
Takahashi, Tohru
Chida, Masanobu
Ohe, Masatoshi
Ohashi, Junko
Ito, Yoshitaka
Sugimura, Akihiko
Ito, Kenta
Matsumoto, Yasuharu
Kawana, Akiko
Tanikawa, Toshinori
Yahagi, Tomoyasu
Tashima, Takurou
Saji, Kenya
Shimokawa, Hiroaki
Fukui, Akio
Fujita, Hiroshi
Kaneko, Junji
Aizawa, Kentaro
Tsuburaya, Ryuji
Kobayashi, Tadashi
Onodera, Sachio
Kato, Atsushi
Sugie, Tadashi
Hiramoto, Tetsuya
Horiguchi, Satoru
Nochioka, Kotaro
Katayose, Dai
Morita, Masaki
Sakata, Yasuhiko
Takeda, Satoru
Iwabuchi, Kaoru
Koseki, Yoshito
Kato, Hiroshi
Nakajima, Sota
Sato, Shoichi
Sugimura, Koichiro
Nakamur
Contributor_xml – sequence: 1
  givenname: Hiroaki
  surname: Shimokawa
  fullname: Shimokawa, Hiroaki
– sequence: 2
  givenname: Toshikazu
  surname: Goto
  fullname: Goto, Toshikazu
– sequence: 3
  givenname: Eiji
  surname: Nozaki
  fullname: Nozaki, Eiji
– sequence: 4
  givenname: Tetsuya
  surname: Hiramoto
  fullname: Hiramoto, Tetsuya
– sequence: 5
  givenname: Mitsumasa
  surname: Fukuchi
  fullname: Fukuchi, Mitsumasa
– sequence: 6
  givenname: Kanichi
  surname: Inoue
  fullname: Inoue, Kanichi
– sequence: 7
  givenname: Atsushi
  surname: Kato
  fullname: Kato, Atsushi
– sequence: 8
  givenname: Masafumi
  surname: Sugi
  fullname: Sugi, Masafumi
– sequence: 9
  givenname: Masatoshi
  surname: Ohe
  fullname: Ohe, Masatoshi
– sequence: 10
  givenname: Tsuyoshi
  surname: Shinozaki
  fullname: Shinozaki, Tsuyoshi
– sequence: 11
  givenname: Satoru
  surname: Horiguchi
  fullname: Horiguchi, Satoru
– sequence: 12
  givenname: Hiroshi
  surname: Kato
  fullname: Kato, Hiroshi
– sequence: 13
  givenname: Masahiko
  surname: Ogata
  fullname: Ogata, Masahiko
– sequence: 14
  givenname: Shoichi
  surname: Sato
  fullname: Sato, Shoichi
– sequence: 15
  givenname: Shigeto
  surname: Oyama
  fullname: Oyama, Shigeto
– sequence: 16
  givenname: Akihiro
  surname: Nakamura
  fullname: Nakamura, Akihiro
– sequence: 17
  givenname: Tohru
  surname: Takahashi
  fullname: Takahashi, Tohru
– sequence: 18
  givenname: Hideaki
  surname: Endo
  fullname: Endo, Hideaki
– sequence: 19
  givenname: Shigefumi
  surname: Fukui
  fullname: Fukui, Shigefumi
– sequence: 20
  givenname: Sota
  surname: Nakajima
  fullname: Nakajima, Sota
– sequence: 21
  givenname: Makoto
  surname: Nakagawa
  fullname: Nakagawa, Makoto
– sequence: 22
  givenname: Tetsuji
  surname: Nozaki
  fullname: Nozaki, Tetsuji
– sequence: 23
  givenname: Takuya
  surname: Yagi
  fullname: Yagi, Takuya
– sequence: 24
  givenname: Etsuko
  surname: Fushimi
  fullname: Fushimi, Etsuko
– sequence: 25
  givenname: Yoshinao
  surname: Sugai
  fullname: Sugai, Yoshinao
– sequence: 26
  givenname: Satoru
  surname: Takeda
  fullname: Takeda, Satoru
– sequence: 27
  givenname: Kouhei
  surname: Fukahori
  fullname: Fukahori, Kouhei
– sequence: 28
  givenname: Kentaro
  surname: Aizawa
  fullname: Aizawa, Kentaro
– sequence: 29
  givenname: Takurou
  surname: Tashima
  fullname: Tashima, Takurou
– sequence: 30
  givenname: Katsuhiko
  surname: Sakurai
  fullname: Sakurai, Katsuhiko
– sequence: 31
  givenname: Tadashi
  surname: Kobayashi
  fullname: Kobayashi, Tadashi
– sequence: 32
  givenname: Motoyuki
  surname: Matsui
  fullname: Matsui, Motoyuki
– sequence: 33
  givenname: Yoshiaki
  surname: Tamada
  fullname: Tamada, Yoshiaki
– sequence: 34
  givenname: Tomoyasu
  surname: Yahagi
  fullname: Yahagi, Tomoyasu
– sequence: 35
  givenname: Akio
  surname: Fukui
  fullname: Fukui, Akio
– sequence: 36
  givenname: Katsuaki
  surname: Takahashi
  fullname: Takahashi, Katsuaki
– sequence: 37
  givenname: Yoku
  surname: Kikuchi
  fullname: Kikuchi, Yoku
– sequence: 38
  givenname: Akihiko
  surname: Sugimura
  fullname: Sugimura, Akihiko
– sequence: 39
  givenname: Junko
  surname: Ohashi
  fullname: Ohashi, Junko
– sequence: 40
  givenname: Hiroyuki
  surname: Kanno
  fullname: Kanno, Hiroyuki
– sequence: 41
  givenname: Junji
  surname: Kaneko
  fullname: Kaneko, Junji
– sequence: 42
  givenname: Shu
  surname: Suzuki
  fullname: Suzuki, Shu
– sequence: 43
  givenname: Kikuyo
  surname: Takahashi
  fullname: Takahashi, Kikuyo
– sequence: 44
  givenname: Kenjiro
  surname: Akai
  fullname: Akai, Kenjiro
– sequence: 45
  givenname: Dai
  surname: Katayose
  fullname: Katayose, Dai
– sequence: 46
  givenname: Sachio
  surname: Onodera
  fullname: Onodera, Sachio
– sequence: 47
  givenname: Seiji
  surname: Komatsu
  fullname: Komatsu, Seiji
– sequence: 48
  givenname: Masanobu
  surname: Chida
  fullname: Chida, Masanobu
– sequence: 49
  givenname: Kaoru
  surname: Iwabuchi
  fullname: Iwabuchi, Kaoru
– sequence: 50
  givenname: Masaharu
  surname: Takeuchi
  fullname: Takeuchi, Masaharu
– sequence: 51
  givenname: Hirokazu
  surname: Yahagi
  fullname: Yahagi, Hirokazu
– sequence: 52
  givenname: Nozomu
  surname: Takahashi
  fullname: Takahashi, Nozomu
– sequence: 53
  givenname: Keiji
  surname: Otsuka
  fullname: Otsuka, Keiji
– sequence: 54
  givenname: Yoshito
  surname: Koseki
  fullname: Koseki, Yoshito
– sequence: 55
  givenname: Masaki
  surname: Morita
  fullname: Morita, Masaki
– sequence: 56
  givenname: Takeshi
  surname: Ishizuka
  fullname: Ishizuka, Takeshi
– sequence: 57
  givenname: Noriko
  surname: Onoue
  fullname: Onoue, Noriko
– sequence: 58
  givenname: Nobuhiro
  surname: Yamaguchi
  fullname: Yamaguchi, Nobuhiro
– sequence: 59
  givenname: Hiroshi
  surname: Fujita
  fullname: Fujita, Hiroshi
– sequence: 60
  givenname: Atsushi
  surname: Katoh
  fullname: Katoh, Atsushi
– sequence: 61
  givenname: Shigeto
  surname: Namiuchi
  fullname: Namiuchi, Shigeto
– sequence: 62
  givenname: Tadashi
  surname: Sugie
  fullname: Sugie, Tadashi
– sequence: 63
  givenname: Kenya
  surname: Saji
  fullname: Saji, Kenya
– sequence: 64
  givenname: Toru
  surname: Takii
  fullname: Takii, Toru
– sequence: 65
  givenname: Toshinori
  surname: Tanikawa
  fullname: Tanikawa, Toshinori
– sequence: 66
  givenname: Osamu
  surname: Kitamukai
  fullname: Kitamukai, Osamu
– sequence: 67
  givenname: Yasuharu
  surname: Matsumoto
  fullname: Matsumoto, Yasuharu
– sequence: 68
  givenname: Jiro
  surname: Koyama
  fullname: Koyama, Jiro
– sequence: 69
  givenname: Tomoko
  surname: Tomioka
  fullname: Tomioka, Tomoko
– sequence: 70
  givenname: Hiroki
  surname: Shioiri
  fullname: Shioiri, Hiroki
– sequence: 71
  givenname: Yoshitaka
  surname: Ito
  fullname: Ito, Yoshitaka
– sequence: 72
  givenname: Chikako
  surname: Takahashi
  fullname: Takahashi, Chikako
– sequence: 73
  givenname: Akiko
  surname: Kawana
  fullname: Kawana, Akiko
– sequence: 74
  givenname: Yasuhiko
  surname: Sakata
  fullname: Sakata, Yasuhiko
– sequence: 75
  givenname: Kenta
  surname: Ito
  fullname: Ito, Kenta
– sequence: 76
  givenname: Masaharu
  surname: Nakayama
  fullname: Nakayama, Masaharu
– sequence: 77
  givenname: Koji
  surname: Fukuda
  fullname: Fukuda, Koji
– sequence: 78
  givenname: Jun
  surname: Takahashi
  fullname: Takahashi, Jun
– sequence: 79
  givenname: Satoshi
  surname: Miyata
  fullname: Miyata, Satoshi
– sequence: 80
  givenname: Koichiro
  surname: Sugimura
  fullname: Sugimura, Koichiro
– sequence: 81
  givenname: Kimio
  surname: Sato
  fullname: Sato, Kimio
– sequence: 82
  givenname: Makoto
  surname: Nakano
  fullname: Nakano, Makoto
– sequence: 83
  givenname: Takashi
  surname: Shiroto
  fullname: Shiroto, Takashi
– sequence: 84
  givenname: Ryuji
  surname: Tsuburaya
  fullname: Tsuburaya, Ryuji
– sequence: 85
  givenname: Kotaro
  surname: Nochioka
  fullname: Nochioka, Kotaro
Copyright 2015 THE JAPANESE CIRCULATION SOCIETY
Copyright_xml – notice: 2015 THE JAPANESE CIRCULATION SOCIETY
CorporateAuthor CHART-2 Investigators
on behalf of the CHART-2 Investigators
CorporateAuthor_xml – name: CHART-2 Investigators
– name: on behalf of the CHART-2 Investigators
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1253/circj.CJ-15-0062
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1347-4820
EndPage 1638
ExternalDocumentID 10_1253_circj_CJ_15_0062
25947000
article_circj_79_7_79_CJ_15_0062_article_char_en
Genre Multicenter Study
Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
Observational Study
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
.55
29B
2WC
53G
5GY
5RE
6J9
AAUGY
ACGFO
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
JSF
JSH
KQ8
M~E
OK1
P2P
RJT
RNS
RZJ
TR2
W2D
X7M
XSB
ZXP
.GJ
3O-
CGR
CUY
CVF
ECM
EIF
NPM
RYR
TKC
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c494t-61cdfecfe23bd3c1c092e2272d1485858fea90683a7a84661a3acfd1532723233
ISSN 1346-9843
IngestDate Fri Jun 28 05:09:24 EDT 2024
Fri Aug 23 02:59:05 EDT 2024
Tue Oct 15 23:53:01 EDT 2024
Thu Aug 17 20:27:09 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c494t-61cdfecfe23bd3c1c092e2272d1485858fea90683a7a84661a3acfd1532723233
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://www.jstage.jst.go.jp/article/circj/79/7/79_CJ-15-0062/_article/-char/en
PMID 25947000
PQID 1692294242
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_1692294242
crossref_primary_10_1253_circj_CJ_15_0062
pubmed_primary_25947000
jstage_primary_article_circj_79_7_79_CJ_15_0062_article_char_en
PublicationCentury 2000
PublicationDate 2015-00-00
PublicationDateYYYYMMDD 2015-01-01
PublicationDate_xml – year: 2015
  text: 2015-00-00
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Circulation Journal
PublicationTitleAlternate Circ J
PublicationYear 2015
Publisher The Japanese Circulation Society
Publisher_xml – name: The Japanese Circulation Society
References 18. Weber M, Arnold R, Rau M, Brandt R, Berkovitsch A, Mitrovic V, et al. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol 2004; 94: 740–745.
20. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle heart failure model: Prediction of survival in heart failure. Circulation 2006; 113: 1424–1433.
4. Varadarajan P, Kapoor N, Bansal RC, Pai RG. Clinical profile and natural history of 453 non-surgically managed patients with severe aortic stenosis. Ann Thorac Surg 2006; 82: 2111–2115.
23. Nochioka K, Sakata Y, Takahashi J, Miyata S, Miura M, Takada T, et al; on behalf of the CHART-2 Investigators. Prognostic impact of nutritional status in asymptomatic patients with cardiac diseases: A report from the CHART-2 Study. Circ J 2013; 77: 2318–2326.
16. Blackshear JL, Wysokinska EM, Safford RE, Thomas CS, Stark ME, Shapiro BP, et al. Indices of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study). Am J Cardiol 2013; 111: 374–381.
34. Brown ML, Pellikka PA, Schaff HV, Scott CG, Mullany CJ, Orszulak TA, et al. The benefits of early valve replacement in asymptomatic patients with severe aortic stenosis. J Thorac Cardiovasc Surg 2008; 135: 308–315.
24. Sakata Y, Miyata S, Nochioka K, Miura M, Takada T, Tadaki S, et al. Gender differences in clinical characteristics, treatment and long-term outcome in patients with stage C/D heart failure in Japan: Report from the CHART-2 study. Circ J 2014; 78: 2276–2283.
32. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343: 611–617.
31. Pellika PA, Nishimura RA, Bailey KR, Tajik AJ. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol 1990; 15: 1012–1017.
33. Ohno M, Hashimoto Y, Suzuki M, Matsumura A, Isobe M. Current state of symptomatic aortic valve stenosis in the Japanese elderly. Circ J 2011; 75: 2474–2481.
6. Shibayama K, Watanabe H, Tabata M, Sasaki S, Takanashi S, Sumiyoshi T, et al. Impact of ejection fraction on long-term outcome after elective aortic valve replacement in octogenarians with aortic stenosis. Circ J 2012; 76: 1761–1767.
9. Bonow RO, Carabello B, Chatterjee K, Otto CM, Shah PM, Shanewise JS, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1988 Guidelines for the Management of Patients With Valvular Heart Disease). Circulation 2006; 114: 450–527.
3. Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005; 111: 3290–3295.
29. Perera S, Wijesinghe N, Ly E, Devlin G, Pasupati S. Outcomes of patients with untreated severe aortic stenosis in real-world practice. NZ Med J 2011; 124: 40–48.
27. Chizner MA, Pearle DL, deLeon AC Jr. The natural history of aortic stenosis in adults. Am Heart J 1980; 99: 419–424.
28. Bouma B, van den Brink RB, van der Meulen JH, Verheul HM, Cheriex EC, Hamer HM, et al. To operate or not on elderly patients with aortic stenosis: The decision and its consequences. Heart 1999; 82: 143–148.
22. Shiba N, Nochioka K, Miura M, Kohno H, Shimokawa H; on behalf of the CHART-2 Investigators. Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan: First report from the CHART-2 study. Circ J 2011; 75: 823–833.
5. Sawa Y, Saito S, Kobayashi J, Niinami H, Kuratani T, Maeda K, et al. First clinical trial of a self-expandable transcatheter heart valve in Japan in patients with symptomatic severe aortic stenosis. Circ J 2014; 78: 1083–1090.
19. Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjørnerheim R, Endresen K, et al. Natriuretic peptides in patients with aortic stenosis. Am Heart J 2001; 142: 725–732.
30. Monin JL, Lancellotti P, Monchi M, Lim P, Weiss E, Piérard L, et al. Risk score for predicting outcome in patients with asymptomatic aortic stenosis. Circulation 2009; 120: 69–75.
21. Pocock SJ, Ariti CA, McMurray JJ, Maggioni A, Køber L, Squire IB, et al. Predicting survival in heart failure: A risk score based on 39372 patients from 30 studies. Eur Heart J 2013; 34: 1404–1413.
11. Japanese Circulation Society. Guidelines for Surgical and Interventional Treatment of Valvular Heart Disease (JCS2012). Available at: www.j-circ.or.jp/guideline/pdf/JCS2012_ookita_h.pdf (in Japanese) (accessed April 20, 2015).
2. Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968; 38(Suppl 1): 61–67.
12. Hachicha Z, Dumesnil JG, Pibarot P. Usefulness of the valvulo-arterial impedance to predict adverse outcome in asymptomatic aortic stenosis. J Am Coll Cardiol 2009; 54: 1003–1011.
15. Bahlmann E, Cramariuc D, Gerdts E, Gohlke-Baerwolf C, Nienaber CA, Eriksen E, et al. Impact of pressure recovery on echocardiographic assessment of asymptomatic aortic stenosis: A SEAS substudy. JACC Cardiovasc Imaging 2010; 3: 555–562.
17. Ky B, French B, Levy WC, Sweitzer NK, Fang JC, Wu AH, et al. Multiple biomarkers for risk prediction in chronic heart failure. Circ Heart Fail 2012; 5: 183–190.
25. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 128: e240–e327, doi:10.1161/CIR.0b013e31829e8776.
8. Henkel DM, Malouf JF, Connolly HA, Michelena HI, Scott CG, Pellikka PA, et al. Asymptomatic left ventricular systolic dysfunction in patients with severe aortic stenosis: Characteristics and outcomes. J Am Coll Cardiol 2012; 60: 2325–2329.
10. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS),Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33: 2451–2496.
13. Garcia D, Pibarot P, Dumesnil JG, Sakr F, Durand LG. Assessment of aortic valve stenosis severity: A new index based on the energy loss concept. Circulation 2000; 100: 765–771.
14. Kume T, Okura H, Kawamoto T, Watanabe N, Hayashida A, Yoshida K, et al. Clinical implication of energy loss coefficient in patients with severe aortic stenosis diagnosed by Doppler echocardiography. Circ J 2008; 72: 1265–1269.
26. World Health Organization. Nutritional anemias: Report of a WHO scientific group. WHO Tech Rep Ser 1968; 405: 3–37.
1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: A population-based study. Lancet 2006; 368: 1005–1011.
7. Kang DH, Park SJ, Rim JH, Yun SC, Kim DH, Song JM, et al. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation 2010; 121: 1502–1509.
26040295 - Circ J. 2015;79(7):1458-9
22
23
24
25
26
27
28
29
30
31
10
32
11
33
12
34
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
References_xml – ident: 8
  doi: 10.1016/j.jacc.2012.08.988
– ident: 25
  doi: 10.1161/CIR.0b013e31829e8776
– ident: 12
  doi: 10.1016/j.jacc.2009.04.079
– ident: 13
  doi: 10.1161/01.CIR.101.7.765
– ident: 10
– ident: 22
  doi: 10.1253/circj.CJ-11-0135
– ident: 30
  doi: 10.1161/CIRCULATIONAHA.108.808857
– ident: 1
  doi: 10.1016/S0140-6736(06)69208-8
– ident: 18
  doi: 10.1016/j.amjcard.2004.05.055
– ident: 20
  doi: 10.1161/CIRCULATIONAHA.105.584102
– ident: 6
  doi: 10.1253/circj.CJ-12-0025
– ident: 15
  doi: 10.1016/j.jcmg.2009.11.019
– ident: 2
  doi: 10.1161/01.CIR.38.1S5.V-61
– ident: 31
  doi: 10.1016/0735-1097(90)90234-G
– ident: 26
– ident: 7
  doi: 10.1161/CIRCULATIONAHA.109.909903
– ident: 9
  doi: 10.1016/j.jacc.2006.05.021
– ident: 14
  doi: 10.1253/circj.72.1265
– ident: 19
  doi: 10.1067/mhj.2001.117131
– ident: 34
  doi: 10.1016/j.jtcvs.2007.08.058
– ident: 23
  doi: 10.1253/circj.CJ-13-0127
– ident: 11
– ident: 17
  doi: 10.1161/CIRCHEARTFAILURE.111.965020
– ident: 28
  doi: 10.1136/hrt.82.2.143
– ident: 21
  doi: 10.1093/eurheartj/ehs337
– ident: 27
  doi: 10.1016/0002-8703(80)90375-0
– ident: 32
  doi: 10.1056/NEJM200008313430903
– ident: 29
– ident: 33
  doi: 10.1253/circj.CJ-11-0012
– ident: 24
  doi: 10.1253/circj.CJ-13-1009
– ident: 4
  doi: 10.1016/j.athoracsur.2006.07.048
– ident: 16
  doi: 10.1016/j.amjcard.2012.10.015
– ident: 3
  doi: 10.1161/CIRCULATIONAHA.104.495903
– ident: 5
  doi: 10.1253/circj.CJ-14-0162
SSID ssj0029059
Score 2.1563864
Snippet Background:The risk of patients with aortic stenosis (AS) should be stratified not only by AS severity but also by comorbidities.Methods and Results:We aimed...
The risk of patients with aortic stenosis (AS) should be stratified not only by AS severity but also by comorbidities. We aimed to develop a risk score for...
BACKGROUNDThe risk of patients with aortic stenosis (AS) should be stratified not only by AS severity but also by comorbidities.METHODS AND RESULTSWe aimed to...
SourceID proquest
crossref
pubmed
jstage
SourceType Aggregation Database
Index Database
Publisher
StartPage 1631
SubjectTerms Age Factors
Aged
Aged, 80 and over
Aortic stenosis
Aortic Valve Stenosis - mortality
Aortic Valve Stenosis - physiopathology
Asian Continental Ancestry Group
Female
Follow-Up Studies
Heart failure
Humans
Japan - epidemiology
Male
Proportional Hazards Models
Prospective Studies
Risk Assessment
Risk score
Sex Factors
Title Comprehensive Risk Stratification of Japanese Patients With Aortic Stenosis – A Proposal of a New Risk Score From the CHART-2 Study
URI https://www.jstage.jst.go.jp/article/circj/79/7/79_CJ-15-0062/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/25947000
https://search.proquest.com/docview/1692294242
Volume 79
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Circulation Journal, 2015/06/25, Vol.79(7), pp.1631-1638
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6gRAviOsoNxmJF4Q8GjupkydUdZ1KWYfEOjGeIsdxaDqpmZrlD_DLOSd2khYxaTzwElWOfdrmfLG_Y58LIe8CE3pSyYwFaZIxPxARi8D6YUOtpUnhhsnwRHd6Jk8vwqOJP-n1muqtXdt_1TS0ga4xcvYftN0KhQb4DDqHK2gdrrfSO77gG7N0funf0HO8zkCLLkEtPZzBEomlJzFDf17HuH3H_dhRgfLQ82tdlHnJ2AgDCa6K0jJWVXtDWpGY_RJYr4tNGU-BFzNeeyXunBOP8412BcLaJBU3Za5AQe0P2x7oPEvbzSBVl37CkKJVvim65ktlqfAPVVbL_LK9M8-ruprSh7kq1bpIqm67IlW2bPdZketlI8xtgtgA0ENjp2zhS-aHfLA9p9sCNQ67cmuCBvrpbS32yEb_upDwuhqIhv-6OhzPmBcwjDbtFs3GUeD0a3x8fnISLyYXiz1yh8N0h3U0jj5_ac3-CBisOyAHqR__lLlDiO6uwCb4aW42d2ras3hIHjh7hY4s0B6Rnlk_JvfmziPjCfm1gzeK4KC7eKNFRhu10gZvFPFGLd7oFt5ogzccpSjgzYlEvFHEGwWYUIc3WuPtKTk_nizGU-bqejDtR_41G3o6zYzODBdJKrSnBxE3nEuegm0O5muYGRUNhqFQUgE9HnpKKJ2lsDZDH8GFeEb218XaPCc0xFPszOeJ5yW-NCaJPEzymfLUCJEIv0_eNw83vrLpW2I0e0ERca2IeDyLvSBGRfTJJ_v0257uJXY9ZRRLvHQjug5LtYHJp0_eNmqLYZbGozd4uEVVxt4w4jzygQ_3yYHVZ_stPIh8CczkxS1GvyT3Ef52D_AV2b_eVOY12SvT6k0Nut9TZsEL
link.rule.ids 315,782,786,4028,27932,27933,27934
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comprehensive+Risk+Stratification+of+Japanese+Patients+With+Aortic+Stenosis--A+Proposal+of+a+New+Risk+Score+From+the+CHART-2+Study&rft.jtitle=Circulation+journal+%3A+official+journal+of+the+Japanese+Circulation+Society&rft.au=Sato%2C+Kenjiro&rft.au=Sakata%2C+Yasuhiko&rft.au=Miura%2C+Masanobu&rft.au=Tadaki%2C+Soichiro&rft.date=2015&rft.eissn=1347-4820&rft.volume=79&rft.issue=7&rft.spage=1631&rft.epage=1638&rft_id=info:doi/10.1253%2Fcircj.CJ-15-0062&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1346-9843&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1346-9843&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1346-9843&client=summon